Publications

Sort by: Date | Author | Title

Madsen, C., Lauridsen, K. L., Plesner, T. L., Monrad, I., Honoré, B., Hamilton-Dutoit, S., d’Amore, F. & Ludvigsen, M. (2019). High intratumoral expression of vimentin predicts histological transformation in patients with follicular lymphoma. Blood Cancer Journal, 9(4), Article 35. https://doi.org/10.1038/s41408-019-0197-5

Madsen, C., Plesner, T. L., Bentzen, H. H. N., Jørgensen, J. M., Sillesen, I. B., Himmelstrup, B. M., Josefsson, P., Plesner, T., Bennedsen, T. L., Ludvigsen, M. & d'Amore, F. A. (2020). Real world data on histological transformation in patients with follicular lymphoma: incidence, clinico-pathological risk factors and outcome in a nationwide Danish cohort. Leukemia & Lymphoma, 61(11), 2584-2594 . https://doi.org/10.1080/10428194.2020.1779254

MacManus, M. P., Seymour, J. F., Tsang, H., Fisher, R., Keane, C., Sabdia, M. B., Law, S. C., Gunawardana, J., Nath, K., Kazakoff, S. H., Marques-Piubelli, M. L., Duenas, D. E., Green, M. R., Roos, D., O'Brien, P., McCann, A., Tsang, R., Davis, S., Christie, D. ... Tobin, J. W. D. (2024). Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma. EBioMedicine, 110, Article 105468. https://doi.org/10.1016/j.ebiom.2024.105468

Lugtenburg, PJ., Brown, P. D. N., Van der Holt, B., D'Amore, F. A., Koene, HR., Berenschot, HW., Fijnheer, R., Loosveld, O., Bohmer, LH., Pruijt, H., Verhoef, G., Hoogendoorn, M., de Kan, R., Van Imhoff, GW., van Hooije, C., Lam, KH., de Keizer, B., de Jong, D., Hoekstra, OS. & Zijlstra, JM. (2016). Randomized phase III study on the effect of early intensification of Rituximab in combination with 2-weekly CHOP chemotherapy flollowed by Rituximab or no maintenance in patients with diffuse large B-cell lymphoma: Results from a HOVON-Nordic Lymphoma Group Study. Abstract from ASCO Annual Meeting, United States.

Lugtenburg, P. J., De Nully Brown, P., Van der Holt, B., D'Amore, F. A., Koene, H. R., De Jongh, E., Fijnheer, R., Van Esser, J. W., Bohmer, L. H., Pruijt, J. F., Verhoef, G. E., Hoogendoorn, M., Bilgin, M. Y., Nijland, M., Van der Burg-De Graauw, N. C., Oosterveld, M., Jie, K. S. G., Larsen, T. S., Van der Poel, M. W. ... Zijlstra-Baalbergen, J. M. (2020). Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84). Journal of Clinical Oncology, 38(29), 3377-3387. https://doi.org/10.1200/JCO.19.03418

Ludvigsen, M., Jacobsen, C., Maunsbach, A. B. & Honoré, B. (2009). Identification and characterization of novel ERC-55 interacting proteins: Evidence for the existence of several ERC-55 splicing variants; including the cytosolic ERC-55-C. Proteomics, 9(23), 5267-5287.

Ludvigsen, M., Ostergaard, M., Vorum, H., Jacobsen, C. & Honoré, B. (2009). Identification and characterization of endonuclein binding proteins: evidence of modulatory effects on signal transduction and chaperone activity. BMC Biochemistry, 10(1), 34. https://doi.org/10.1186/1471-2091-10-34

Ludvigsen, M., Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Moeller, M. B., Noergaard, P., D'Amore, F. A. & Honoré, B. (2013). Proteomic analysis identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified. Hematological Oncology, 31, 174-175.

Ludvigsen, M., Madsen, C., Kamper, P., Hamilton-Dutoit, S. J., Bendix, K., D'Amore, F. A. & Honoré, B. (2013). Proteomic analysis identifies differential expression patterns in follicular lymphoma patients with or without subsequent histological transformation. Hematological Oncology, 31, 203.

Ludvigsen, M., Kamper, P., Sørensen, B. S., Møller, M. B., Bendix, K., Hamilton-Dutoit, S. J., Alsner, J., D'Amore, F. A. & Honoré, B. (2015). Differential protein expression of peroxiredoxin-1 in classical Hodgkin Lymphoma: a possible correlation to clinical behaviour. Hematological Oncology, 33, 253-255. https://doi.org/10.1002/hon.2157

Ludvigsen, M., Kamper, P., Hamilton-Dutoit, S. J., Bendix, K., Møller, M. B., d'Amore, F. A. & Honoré, B. (2015). Relationship of intratumoural protein expression patterns to age and Epstein-Barr virus status in classical Hodgkin lymphoma. European Journal of Haematology, 95(2), 137-149. https://doi.org/10.1111/ejh.12463

Ludvigsen, M., Hamilton-Dutoit, S. J., D'Amore, F. A. & Honoré, B. (2015). Proteomic approaches to the study of malignant lymphoma: analyses on patient samples. Proteomics - Clinical Applications, 9, 72-85. https://doi.org/10.1002/prca.201400145

Ludvigsen, M., Madsen, C., Kamper, P., Hamilton-Dutoit, S. J., Bendix, K., D'Amore, F. A. & Honoré, B. (2015). Histologically transformed follicular lymphoma exhibits protein profiles different from both non-transformed follicular and de novo diffuse large B-cell lymphoma. Blood Cancer Journal, 5, Article e293. https://doi.org/10.1038/bcj.2015.18

Ludvigsen, M., Pedersen, M. B., Poulsen, T. S., Hamilton-Dutoit, S. J., Besenbacher, S., Bendix, K., Møller, M. B., D'Amore, F. A. & Honoré, B. (2014). Proteomic Analysis Identifies Outcome-Predictive Clusters in Patients with Peripheral T-Cell Lymphoma, Not otherwise specified: Proteomic Analysis Identifies Outcome-Predictive Clusters in Patients with Peripheral T-Cell Lymphoma, Not otherwise specified. Blood, 124(21), Article 124.

Ludvigsen, M., Kamper, P., Bendix, K., Hamilton Dutoit, S. J., Rabinovich, G. A., Møller, M. B., Nyengaard, J. R., D'Amore, F. A. & Honoré, B. (2011). Translational research identifies prognostic markers including galectin-1 in the tumor microenvironment of cHL predictive for relapsed /refractory disease.

Ludvigsen, M., Kamper, P., Sørensen, B. S., Hamilton Dutoit, S. J., Bendix, K., Møller, M. B., Alsner, J., D'Amore, F. A. & Honoré, B. (2013). Specific degradation pattern of peroxiredoxin-1 correlates with adverse outcome in classical Hodgkin lymphoma patients..

Ludvigsen, M., Vase, M. Ø., Larsen, C. S., D'Amore, F. A. & Honoré, B. (2015). Differentially expressed proteins at HIV diagnosis identify patients subsequently developing either no, benign or malignant lymphadenopathy – a proteomic analysis.

Ludvigsen, M., Vase, M. Ø., Bendix, K., Hamilton Dutoit, S. J., Rabinovich, G. A., Møller, M. B., Pedersen, C., Pedersen, G., Obel, N., Larsen, C. S. & D'Amore, F. A. (2016). High Intratumoral Expression of Galectin-1 Correlated with Superior Outcome in HIV-associated DLBCL..

Ludvigsen, M. (2014). Protein profiling of lymphomas. Identification and characterization of disease markers and drug targets: PhD dissertation.

Ludvigsen, M. (2007). Affinity purification and identification of ERC-55 interacting proteins: Master dissertation.

Ludvigsen, M., Vase, M. Ø., Hjortebjerg, R., Petruskevicius, I., Pedersen, C., Pedersen, G., Sørensen, B., Bjerre, M., Obel, N., Honoré, B., Larsen, C. S. & d'Amore, F. (2016). Low Serum Galectin-1 Levels Predict Future Lymphoma Development in HIV-Positive Patients. Blood, 128(22), Article 2945.

Ludvigsen, M. & Honoré, B. (2018). Transcriptomics and Proteomics: Integration? In Transcriptomics and proteomics: Integration? (pp. 1-9)

Ludvigsen, M., Bjerregård Pedersen, M., Lystlund Lauridsen, K., Svenstrup Poulsen, T., Hamilton-Dutoit, S. J., Besenbacher, S., Bendix, K., Møller, M. B., Nørgaard, P., d'Amore, F. & Honoré, B. (2018). Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified. Blood Advances, 2(19), 2533-2542. https://doi.org/10.1182/bloodadvances.2018019893

Ludvigsen, M., Thorlacius-Ussing, L., Vorum, H., Moyer, M. P., Stender, M. T., Thorlacius-Ussing, O. & Honoré, B. (2020). Proteomic Characterization of Colorectal Cancer Cells versus Normal-Derived Colon Mucosa Cells: Approaching Identification of Novel Diagnostic Protein Biomarkers in Colorectal Cancer. International Journal of Molecular Sciences , 21(10), Article 3466. https://doi.org/10.3390/ijms21103466

Ludvigsen, M., Thorlacius-Ussing, L., Vorum, H., Stender, M. T., Thorlacius-Ussing, O. & Honoré, B. (2021). Proteomic Characterization of Colorectal Cancer Tissue from Patients Identifies Novel Putative Protein Biomarkers. Current Issues in Molecular Biology, 43(2), 1043-1056. https://doi.org/10.3390/cimb43020074

Ludvigsen, L. U. P., Andersen, A. S., Hamilton-Dutoit, S., Jensen-Fangel, S., Bøttger, P., Handberg, K. J., Ivarsen, P., d'Amore, F., Bibby, B. M., Albertsen, B. K., Jespersen, B. & Thomsen, M. K. (2023). A prospective evaluation of the diagnostic potential of EBV-DNA in plasma and whole blood. Journal of Clinical Virology, 167, Article 105579. https://doi.org/10.1016/j.jcv.2023.105579

Ludvigsen, M., Campbell, A. J., Enemark, M. B., Hybel, T. E., Karjalainen-Lindsberg, M.-L., Beiske, K., Bjerre, M., Pedersen, L. M., Holte, H., Leppä, S., Jørgensen, J. M. & Honoré, B. (2023). Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma. Blood Cancer Journal, 13(1), Article 161. https://doi.org/10.1038/s41408-023-00931-6

Ludvigsen, L. U. P., Åsberg, A., Spetalen, S., Sørensen, M. D., Hamilton-Dutoit, S., Gramkow, A. M., Christiansen, C. F., Kro, G. B., Thomsen, M. K., Ulrichsen, S. P., Pedersen, R. M., Holte, H., Thiesson, H. C., Bjerre, A., D'Amore, F., Dahle, D. O., Jespersen, B., Jensen-Fangel, S. & Reisæter, A. V. (2025). Risk and prognosis of posttransplant lymphoproliferative disease in Epstein-Barr virus-seronegative kidney transplant recipients: an observational cohort study from Norway and western Denmark. American Journal of Transplantation, 25(7), 1547-1560. https://doi.org/10.1016/j.ajt.2025.01.035

Luchtel, R. A., Dasari, S., Oishi, N., Pedersen, M. B., Hu, G., Rech, K. L., Ketterling, R. P., Sidhu, J., Wang, X., Katoh, R., Dogan, A., Kip, N. S., Cunningham, J. M., Sun, Z., Baheti, S., Porcher, J. C., Said, J. W., Jiang, L., Hamilton-Dutoit, S. J. ... Feldman, A. L. (2018). Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements. Blood, 132(13), 1386-1398. https://doi.org/10.1182/blood-2018-03-838524

Leivonen, S.-K., Icay, K., Jäntti, K., Siren, I., Liu, C., Alkodsi, A., Cervera, A., Ludvigsen, M., Hamilton-Dutoit, S. J., d'Amore, F., Karjalainen-Lindsberg, M.-L., Delabie, J., Holte, H., Lehtonen, R., Hautaniemi, S. & Leppä, S. (2017). MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma. Blood Cancer Journal, 7(12), 654. Article 654. https://doi.org/10.1038/s41408-017-0033-8

Leivonen, S. K., Friman, T., Autio, M., Vaittinen, S., Jensen, A. W., d’Amore, F., Hamilton-Dutoit, S. J., Holte, H., Beiske, K., Kovanen, P. E., Räty, R. & Leppä, S. (2023). Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas. Haematologica, 108(11), 3044-3057. https://doi.org/10.3324/haematol.2023.282831

Kwong, YL., Kim, SJ., Tse, E., Oh, SJ., Kwak, JY., Eom, HS., Do, YR., Mun, YC., Lee, SR., Shin, HJ., Suh, C., Chuang, SS., Tan, D., Lim, ST., Izutsu, K., Suzuki, R., Relander, T., d'Amore, F. A., Schmitz, N. ... Kim, WS. (2018). Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma. Annals of Oncology, 29(1), 256–263. https://doi.org/10.1093/annonc/mdx684

Kucuk, C., Jiang, B., Hu, X., Gaulard, P., Zhang, W., Xiao, W., Staudt, LM., Iqbal, J., Cornish, A., Kavak, P., Alkan, C., Gong, Q., Yang, Q., Sun, H., D'Amore, F. A., Leppa, S., Liu, W., McKeithan, T. & Chan, WC. (2013). Frequent activating mutations of JAK-Stat Pathway genes in natural killer cell lymphomas. Blood.

Krogh-Jensen, M., d'Amore, F. A. & Jensen, MK. (1994). Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO. Annals of Oncology, 5((4)), 349-54.

Krogh-Jensen, M., d'Amore, F. A. & Jensen, MK. (1995). Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous sysem lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry. Leukemia & Lymphoma, 19((3-4)), 223-33.

Krogh-Jensen, M., d'Amore, F. A. & Jensen, MK. (1996). Primary cerebral non-Hodgkin's lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the registry of non-Hodgkin's lymphoma in western Denmark, LYFO and the cancer registry, Kræftens Bekæmpelse. Ugeskrift for Læger, 158((31)), 4406-12.

Krogh-Jensen, M., Johansen, P. & d'Amore, F. A. (1998). Primary central nervous system lymphomas in immunocompetent individuals: histology, Epstein-Barr viurs genome, Ki-67 proliferation index, p53 and bcl-2 gene expression. Leukemia & Lymphoma, 30((1-2)), 131-42.

Kim, S. J., Yoon, D. H., Jaccard, A., Chng, W. J., Lim, S. T., Hong, H., Park, Y., Chang, K. M., Maeda, Y., Ishida, F., Shin, D.-Y., Kim, J. S., Jeong, S. H., Yang, D.-H., Jo, J.-C., Lee, G.-W., Choi, C. W., Lee, W.-S., Chen, T.-Y. ... Kim, W. S. (2016). A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. Lancet Oncology, 17(3), 389-400. https://doi.org/10.1016/S1470-2045(15)00533-1

Kim, S. J., Lim, J. Q., Laurensia, Y., Cho, J., Yoon, S. E., Lee, J. Y., Ryu, K. J., Ko, Y. H., Koh, Y., Cho, D., Lim, S. T., Beck Enemark, M., D'amore, F., Bjerre, M., Ong, C. K. & Kim, W. S. (2020). Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 study. Blood, 136(24), 2754-2763. https://doi.org/10.1182/blood.2020007247

Kilpivaara, O., Ristolainen, H., Kamper, P., Taskinen, M., Saarinen, S., Leppä, S., D'Amore, F. A. & Lauri, A. A. (2014). Identification of novel germline variants in early-onset familial classical Hodgkin lymphoma with exome sequencing. Blood, 121(24).

Kharfan-Dabaja, M. A., Kumar, A., Ayala, E., Hamadani, M., Reimer, P., Gisselbrecht, C., d'Amore, F., Jantunen, E., Ishida, T., Bazarbachi, A., Foss, F., Advani, R., Fenske, T. S., Lazarus, H. M., Friedberg, J. W., Aljurf, M., Sokol, L., Tobinai, K., Tse, E. ... Savani, B. N. (2017). Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T-Cell and NK/T-Cell Lymphomas: an International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation, 23(11), 1826-1838. https://doi.org/10.1016/j.bbmt.2017.07.027

Kelsen, J., Schwindt, H., Dige, A. K., D'Amore, F. A., Pedersen, F. S., Agnholt, J., Christensen, L. A., Dahlerup, J. F. & Hvas, C. L. (2011). Infliximab Induces Clonal Expansion of γδ-T Cells in Crohn’s Disease: A Predictor of Lymphoma Risk? PLoS One, 6(3), e17890. https://doi.org/10.1371/journal.pone.0017890

Kelsen, J., Schwindt, H., Dige, A. K., D'Amore, F. A., Pedersen, F. S., Agnholt, J., Christensen, L. A., Dahlerup, J. F. & Hvas, C. L. (2010). Infliximab drives gamma-delta T cell expansion in Crohn's disease - a predictor of lymphoma risk? Blood, 116(21), 4131.

Kelsen, J., Dige, A. K., Christensen, M., D'Amore, F. A. & Iversen, L. (2014). Frequency and clonality of peripheral gamma delta T-cells in psoriasis patients receiving Anti-TNF-alfa therapy. Clinical and Experimental Immunology, 177/1(142-48).

Kelsen, J., Dige, A., Christensen, M., D'Amore, F. & Iversen, L. (2014). Frequency and clonality of peripheral γδ T cells in psoriasis patients receiving anti-TNF-α therapy. Clinical and Experimental Immunology, 177(1), 142–148. https://doi.org/10.1111/cei.12331

Kamper, P., Kjeldsen, E., Clausen, N., Bendix, K., Hamilton-Dutoit, S. & d'Amore, F. (2005). Epstein-Barr virus-associated familial Hodgkin lymphoma: paediatric onset in three of five siblings. British Journal of Haematology, 129(5), 615-7. https://doi.org/10.1111/j.1365-2141.2005.05499.x

Kamper, P., Bendix, K., Hamilton-Dutoit, S., Honoré, B., Nyengaard, J. R. & d'Amore, F. (2011). Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma. Haematologica, 96(2), 269-76. https://doi.org/10.3324/haematol.2010.031542

Kamper, P., Bendix, K., Hamilton-Dutoit, S., Honoré, B. & D'Amore, F. A. (2012). Epstein-Barr Virus Status Correlates with Composition and Prognostic Impact of the Tumour Microenvironment in Classical Hodgkin Lymphoma. Blood, 120(52).

Kamper, P., Bendix, K., Honoré, B., D'Amore, F. A. & Hamilton-Dutoit, S. J. (2012). Epstein-Bar Virus Status Correlates with Composition and Prognostic Impact of the Tumor Microenvironment in Classical Hodgkin Lymphoma: Epstein-Bar Virus Status Correlates with Composition and Prognostic Impact of the Tumor Microenvironment in Classical Hodgkin Lymphoma. Abstract from 54th ASH Annual Meeting and Exposition, Atlanta, GA, United States.

Kamper, P., Bendix, K., Hamilton-Dutoit, S. J., Honoré, B. & D'Amore, F. A. (2012). Epstein-Bar Virus Status Correlates with Composition and Prognostic Impact of the Tumor Microenvironment in Classical Hodgkin Lymphoma: Epstein-Bar Virus Status Correlates with Composition and Prognostic Impact of the Tumor Microenvironment in Classical Hodgkin Lymphoma. Blood, 120(21), Article 120.

Displaying results 101 to 150 out of 284

Revised 15.03.2021

Francesco Annibale d'Amore